Bifogade filer
Year End Report Q4 2023
Kurs
+2,84%
Likviditet
0,67 MSEK
Prenumeration
Kalender
| Tid* | ||
| 2025-02-11 | 18:00 | Bokslutskommuniké 2024 |
| 2024-11-01 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-15 | - | Kvartalsrapport 2024-Q2 |
| 2024-06-26 | - | Årsstämma |
| 2024-04-26 | - | X-dag ordinarie utdelning BRAIN 0.00 SEK |
| 2024-04-15 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-29 | - | Bokslutskommuniké 2023 |
| 2023-11-30 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-31 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-31 | - | Kvartalsrapport 2023-Q1 |
| 2023-05-12 | - | X-dag ordinarie utdelning BRAIN 0.00 SEK |
| 2023-05-11 | - | Årsstämma |
| 2023-02-28 | - | Bokslutskommuniké 2022 |
| 2023-02-15 | - | Extra Bolagsstämma 2022 |
| 2022-11-30 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-31 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-31 | - | Kvartalsrapport 2022-Q1 |
| 2022-05-12 | - | X-dag ordinarie utdelning BRAIN 0.00 SEK |
| 2022-05-11 | - | Årsstämma |
| 2022-02-28 | - | Bokslutskommuniké 2021 |
| 2021-11-30 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-26 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-31 | - | Kvartalsrapport 2021-Q1 |
| 2021-04-16 | - | X-dag ordinarie utdelning BRAIN 0.00 SEK |
| 2021-04-15 | - | Årsstämma |
| 2021-02-26 | - | Bokslutskommuniké 2020 |
| 2020-11-27 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-28 | - | Kvartalsrapport 2020-Q2 |
| 2020-07-01 | - | X-dag ordinarie utdelning BRAIN 0.00 SEK |
| 2020-06-30 | - | Årsstämma |
| 2020-05-29 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-28 | - | Bokslutskommuniké 2019 |
| 2019-11-08 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-30 | - | Kvartalsrapport 2019-Q2 |
| 2019-06-17 | - | Årsstämma |
| 2019-04-08 | - | X-dag ordinarie utdelning BRAIN 0.00 SEK |
| 2019-02-28 | - | Bokslutskommuniké 2018 |
| 2018-11-16 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-27 | - | Kvartalsrapport 2018-Q2 |
| 2018-07-25 | - | Extra Bolagsstämma 2018 |
| 2018-05-09 | - | Kvartalsrapport 2018-Q1 |
| 2018-04-19 | - | X-dag ordinarie utdelning BRAIN 0.00 SEK |
| 2018-04-18 | - | Årsstämma |
| 2018-02-16 | - | Bokslutskommuniké 2017 |
| 2017-11-23 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-10 | - | Kvartalsrapport 2017-Q2 |
| 2017-06-29 | - | Årsstämma |
| 2017-05-15 | - | Kvartalsrapport 2017-Q1 |
| 2017-04-24 | - | Extra Bolagsstämma 2017 |
| 2017-04-12 | - | X-dag ordinarie utdelning BRAIN 0.00 SEK |
| 2017-02-14 | - | Bokslutskommuniké 2016 |
| 2016-11-10 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-25 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-10 | - | Kvartalsrapport 2016-Q1 |
| 2016-04-14 | - | Årsstämma |
| 2016-03-27 | - | X-dag ordinarie utdelning BRAIN 0.00 SEK |
| 2016-01-28 | - | Bokslutskommuniké 2015 |
| 2015-10-22 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-26 | - | Kvartalsrapport 2015-Q2 |
| 2015-04-28 | - | Kvartalsrapport 2015-Q1 |
| 2015-03-27 | - | X-dag ordinarie utdelning BRAIN 0.00 SEK |
| 2015-03-26 | - | Årsstämma |
| 2015-01-27 | - | Bokslutskommuniké 2014 |
| 2014-10-20 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-19 | - | Kvartalsrapport 2014-Q2 |
| 2014-06-26 | - | X-dag ordinarie utdelning BRAIN 0.00 SEK |
| 2014-06-25 | - | Årsstämma |
| 2014-04-14 | - | Extra Bolagsstämma 2014 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Correction addresses the number of delivered system for quarter four.
Jon Berg, CEO Comments
“Unfortunately, BrainCool has published an incorrect number of delivered systems in the CEO comments for quarter four. This has no impact on the financial statements.
The correct comment should be:
We succeeded in delivering around 25 systems in December and in total 37 systems for quarter four. For the year as whole, we delivered over 70 systems.
We are very sorry for the mistake.”
Contact
For more information
Jon Berg - CEO
+46 722 50 91 19
e-mail: jon.berg@braincool.se
About Us
BrainCool AB (publ) is an innovative medical device company that develops, markets, and sells leading medical cooling systems for indications and areas with significant medical benefits within the healthcare sector. BrainCool AB (publ) is based in Lund, Sweden, and its share is listed on Nasdaq First North Growth Market, named “BRAIN”.
Eminova Fondkommission AB is the company’s Certified Adviser.
This information is information that BrainCool is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-02-29 17:45 CET.
Attachments
Year End Report Q4 2023 Correction